Module 1 2021

01/07/2021

History

The Organisation for Professionals in Regulatory Affairs

3

Many medicines used in children are not studied in the paediatric population

• Conducting clinical studies in children is difficult • Ethical considerations • Few patients • Measuring of disease progression and AE’s can be problematic • Different age groups

The Organisation for Professionals in Regulatory Affairs

4

2